Molecular Urinary Sediment Analysis in Patients with Transitional Cell Bladder Carcinoma

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 5095-5100

  Dal Canto, Maurizio ^a   Bartoletti, Riccardo ^a   Travaglini, Fabrizio ^a   Piazzini, Mauro ^a   Lodovichi, Giulia ^a   Rizzo, Michelangelo ^a   Selli, Cesare ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Early diagnosis; Microsatellite analysis; Transitional cell carcinoma; Tumor markers; Urinary sediment

Indexed keywords

BCG VACCINE; MICROSATELLITE DNA; TUMOR MARKER;

ALLELIC EXCLUSION; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER EPIDEMIOLOGY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; DRUG ADMINISTRATION; DYSPLASIA; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROSATELLITE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; TUMOR DIAGNOSIS; URINALYSIS; URINE CYTOLOGY; URINE SEDIMENT;

CARCINOMA, TRANSITIONAL CELL; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS; URINE;

EID: 0842278702     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. CA 47(1): 5-27, 1997.
2. Wawroschek F and Rathert P: Urine cytology. Urologe A 34: 69-75, 1995.
3. Farrow GM, Utz DC and Rife CC: Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res 36: 2495-2501, 1976.
4. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN and Ford KS: Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 53: 1555-1565, 1984.
5. Sarnacki CT, McCormack LJ, Kiser WS, Hazard JB, McLaughlin TC and Belovich DM: Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1400 patients. J Urol 106: 761-764, 1971.
6. Johnstone B, Morales A, Emerson L et al: Rapid detection of bladder cancer: a comparative study of point of care tests. J Urol 158: 2098-2101, 1997
7. Heicappell R, Wetting IC, Schostak M et al: Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of urinary bladder. Eur Urol 35: 81-87, 1999.
8. Wiener HG, Mian CH, Haitel A, Pycha A, Schatzl G and Marberger M: Can urine bound diagnostic tests replace cystoscopy in management of bladder cancer?, J Urol 159: 1876-1880, 1998.
9. Orlow Lianes P, Dalbagni G, Reuter VE and Cordon Cardo C: Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54: 2848-2851, 1994
10. Sandberg AA and Berger CS: Review of chromosome studies in urological tumors. Cytogenetics and molecular genetics of bladder cancer. J Urol 151: 545-560, 1994.
11. Presti JC, Reuter VE, Galan T, Fair WR and Cordon Cardo C: Molecular genetics alterations in superficial and locally advanced human bladder cancer. Cancer Res 51: 5405-5409, 1991.
12. Polasik J, Cairns P, Chang WYH, Schoenberg MP and Sidransky D: Distinct regions of allelic loss on chromosome 4 in human bladder carcinoma. Cancer Res 55: 5396-5399, 1995.
13. Knowles MA, Shaw ME and Proctor AJ: Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphism and microsatellites polymorphisms. Oncogene 8: 1357-1364, 1993.
14. Fearon ER, Feinberg AP, Hamilton SH and Voegelstein B: Loss of genes on the short arm of the chromosome 11 in bladder cancer. Nature (Lond) 318: 377-380, 1985.
15. Olumi AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bender LI and Jones PA: Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res 50: 7081-7083, 1990.
16. Ruppert JM, Tokino K and Sidransky D: Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53: 5093-5095, 1993.
17. Nawroz H, Van der Riet P, Hruban RH, Koch W, Ruppert JM and Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152-1155, 1994.
18. Wistuba LL, Lam S, Behress C, Virman AK, Fong KM, Leriche J, Samel JM, Srivastann S, Minna JD and Gzdar AF: Molecular damage in the bronchial epithelium of current and former smokers. J Nat Cancer Inst 89: 1366-1373, 1996.
19. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Maslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R and Halling KC: Altered expression of hMHS2 and hMLH1 in tumors with microsatellites instability and genetic alterations in mismatch repair genes. Cancer Res 56: 4836-4840, 1996.
20. Peltomaky P et al: Microstaellites instability is associated with tumors that characterize the hereditary non-polyposic colorectal carcinoma syndrome. Cancer Res 53: 5853-5855, 1993.
21. Tangir J, Loeghridge NS, Berkowitz RS, Muto MG, Bell DA, Welch WR and Mor SC: Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res 56: 2501-2505, 1996.
22. Gonzalez-Zulueta M et al: Microsatellites instability in bladder cancer. Cancer Res 53: 5620-5623, 1995.
23. Sandberg AA and Berger CS: Review of chromosome studies in urological tumors. Cytogenetics and molecular genetics of bladder cancer. J Urol 151: 545-560, 1994.
24. Cairns P, Tokino K, Eby Y and Sidransky D: Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54: 1422-1224, 1994.
25. Aaltonen LA et al: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993.
26. Cairns P, Polashik TJ, Eby Y et al: Frequency of homozygous deletion at P16/CDKN2 in primary human tumor. Nature Genetics 11: 210, 1995.
27. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D and Sidransky D: Molecular detection of primary bladder cancer by microsatellite analysis. Science 271: 659-662, 1996.
28. Mao L, Lee DJ, Tockman MS et al: Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 91: 9871-9875, 1994.
29. Mourah S, Cussenot O, Vimont V, Desgrandchamps F, Tellanc P, Cochant-Priollut B, Li Duc A, Fift J and Soliman H: Assesment of microsatellite instability in urine in the detection of transitional cell carcinoma of the bladder. Int J Cancer Pre Oncol 70: 629-633, 1998.
30. Steiner G, Schoenberg MP, Linn LE, Mao L and Sidransky D: Detection of bladder cancer recurrence by microsatellites analysis of urine. Nature Med 3: 621-624, 1997.
31. Lunee J, Challen C, Melton K and Neal DF: c-ERB-B2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet 339: 439-440, 1992.
32. Xu X, Stower MJ, Rho NL, Garntr RC and Burns PA: Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations biomarkers. Clin Cancer Res 2: 1795-1800, 1996.